Projects funded by the NCN

Foreign investments controls motivated by national security concerns: a comparative analysis of the legal regimes in the...

Call: PRELUDIUM BIS 2 , Panel: HS5

Principal investigator: dr hab. Łukasz Adam Gruszczyński

Akademia Leona Koźmińskiego

Cell-based high-throughput screening for small-molecule compounds diminishing molecular markers of pathogenesis in myoto...

Call: OPUS 20 , Panel: NZ3

Principal investigator: dr hab. Marzena Wojciechowska

Instytut Chemii Bioorganicznej PAN

Input of the structure of influenza A virus RNA on regulation of virus proliferation. High throughput screening of small...

Call: OPUS 20 , Panel: NZ1

Principal investigator: prof. Elżbieta Beata Kierzek

Instytut Chemii Bioorganicznej PAN

Towards automatic derivation of geometry-based descriptors as surrogates for complex structural approaches in enzyme-sub...

Call: PRELUDIUM 19 , Panel: NZ2

Principal investigator: Carlos Eduardo Sequeiros Borja

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

Screening for new therapeutic targets in inherited retinal diseases based on protein-protein interactions analysis

Call: POLS , Panel: NZ4

Principal investigator: dr Xiaonan Liu

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

Bioactivity screening of antiparasitic drugs in vitro - transcriptomic and metabolomic studies on parasitic nematode Ani...

Call: PRELUDIUM 19 , Panel: NZ9

Principal investigator: Iwona Polak

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Biologii i Biotechnologii

Printing of self-assembling droplet arrays: from basic physics to applications in cell encapsulation and high-throughput...

Call: SONATA BIS 9 , Panel: ST8

Principal investigator: dr Jan Jerzy Guzowski

Instytut Chemii Fizycznej Polskiej Akademii Nauk

Oligomer-Focused Screening and Individualized Therapeutics to target Neurodegenerative Disorders

Call: JPND2019 , Panel: NZ1

Principal investigator: dr Piotr Hańczyc

Uniwersytet Warszawski, Wydział Fizyki

Metabolites of Baltic cyanobacteria as natural compound library for high throughput screening and the development of new...

Call: OPUS 17 , Panel: NZ9

Principal investigator: prof. Hanna Jurata Mazur-Marzec

Uniwersytet Gdański, Wydział Chemii

Screening new candidate genes involved in the development of monogenic diabetes

Call: PRELUDIUM 1 , Panel: NZ5

Principal investigator: Karolina Elżbieta Antosik

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Development of a comprehensive set of computational tools for the search of new ligands of particular receptor - case st...

Call: OPUS 16 , Panel: NZ2

Principal investigator: dr hab. Sabina Marta Podlewska

Instytut Farmakologii PAN

Genome-wide siRNA screening for proteins involved in the maintenance of human mitochondrial genome

Call: SONATA 14 , Panel: NZ2

Principal investigator: dr Łukasz Stanisław Borowski

Uniwersytet Warszawski, Wydział Biologii

Identification and characterization of new epigenetic factors responsible for regulation of self-renewal in hematopoieti...

Call: HARMONIA 10 , Panel: NZ3

Principal investigator: dr Eliza Głodkowska-Mrówka

Warszawski Uniwersytet Medyczny, I Wydział Lekarski

In search for new genes involved in primary ciliary dyskinesia pathogenesis: functional screening of candidate genes usi...

Call: PRELUDIUM 15 , Panel: NZ5

Principal investigator: Alicja Małgorzata Rabiasz

Instytut Genetyki Człowieka PAN

Fighting antibiotic-resistant superbugs with anti-persister compounds targeting the strigent response

Call: UNISONO , Panel: NZ6

Principal investigator: dr hab. Ewa Laskowska

Uniwersytet Gdański

Metabolomics and radiomics signature of early lung cancer

Call: OPUS 14 , Panel: NZ7

Principal investigator: prof. Piotr Michał Widłak

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Exosome biosensors - new tools in cancer screening, diagnostics and development of targeted drug delivery system

Call: OPUS 13 , Panel: ST4

Principal investigator: dr hab. Magdalena Stobiecka

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

Fast screening analysis of the breath phase and plasma in patients with pulmonary arterial hypertension.

Call: PRELUDIUM 13 , Panel: NZ5

Principal investigator: Błażej Krzysztof Kusz

Śląski Uniwersytet Medyczny w Katowicach, Wydział Lekarski w Katowicach

An integrated screening platform for determination of human proteasomes extended substrate specificity

Call: OPUS 13 , Panel: ST5

Principal investigator: prof. Marcin Drąg

Politechnika Wrocławska

Development of protocol for in silico design of compounds inhibit Ebola virus infection

Call: PRELUDIUM 11 , Panel: NZ2

Principal investigator: Dawid Zdzisław Warszycki

Instytut Farmakologii PAN

Searching for genetic determinants of malignancy in follicular thyroid lesions employing genomic screening

Call: PRELUDIUM 10 , Panel: NZ5

Principal investigator: Martyna Joanna Borowczyk

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

Deciphering BMP6 regulatory mechanisms using CRISPR/Cas9-based screening approach

Call: POLONEZ 1 , Panel: NZ2

Principal investigator: dr Katarzyna Maria Mleczko-Sanecka

Instytut Genetyki i Hodowli Zwierząt PAN

A virtual screening protocol based on automatically generated structure-based pharmacophore models.

Call: HARMONIA 7 , Panel: NZ2

Principal investigator: Stefan Mateusz Mordalski

Instytut Farmakologii PAN

Searching for the new lead structures for 5-HT7 serotonin receptor ligands with increased metabolic stability.

Call: HARMONIA 7 , Panel: NZ7

Principal investigator: Sabina Marta Podlewska

Instytut Farmakologii PAN

Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist...

Call: OPUS 9 , Panel: NZ7

Principal investigator: prof. Mariusz Papp

Instytut Farmakologii PAN

The application of a modern chromatographic platform with biodetection: HPLC-DAD/MAO A/ESI-TOF-MS in the antidepressant ...

Call: SONATA 9 , Panel: NZ7

Principal investigator: dr hab. Wirginia Anna Kukuła-Koch

Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny